Illinois Fertility Insurance Mandate: What Clinics Must Bill

Illinois has maintained one of the longest-running fertility insurance mandates in the United States. The original mandate dates to 1991, and legislative expansions since then have broadened the scope of required coverage significantly. For fertility practices serving patients on Illinois-regulated group health plans, mastering the mandate's exact requirements — and the billing protocols that flow from them — is the difference between capturing every dollar of legitimate reimbursement and losing revenue to preventable authorization failures and uncollectible claim denials.

This post covers the statutory foundation of the Illinois mandate, the full scope of covered services, applicable CPT and ICD-10 codes, carrier-specific prior authorization requirements, FET billing rules, and the most frequent coding and workflow errors that generate claim denials under Illinois-mandated plans.

The Statutory Foundation: 215 ILCS 5/356m

The Illinois fertility insurance mandate is codified in 215 ILCS 5/356m of the Illinois Insurance Code. The statute requires group accident and health insurance policies delivered or issued in Illinois to cover the diagnosis and treatment of infertility. Illinois was among the earliest states to enact a comprehensive IVF mandate, and the law has been updated multiple times over the past three decades — most notably to remove limitations that previously excluded certain patient populations and to expand the definition of covered individuals.

The mandate applies to group health insurance plans issued or renewed in Illinois for employers with 25 or more eligible employees, but only to fully insured plans. Self-funded employer plans governed by ERISA are exempt from state insurance mandates by federal preemption. This is the single most consequential exclusion for billing staff to understand: misidentifying a self-funded plan as mandate-compliant is the leading source of uncollectible fertility claims in Illinois practices. Confirm plan funding type in writing before any cycle begins.

Illinois defines infertility for mandate purposes as the inability to conceive or carry a pregnancy to live birth after 12 months of unprotected sexual intercourse for patients under 35, or 6 months for patients 35 and older. For same-sex couples and single individuals, Illinois does not require the same duration of attempted conception as opposite-sex couples. The mandate requires carriers to apply a clinically appropriate therapeutic donor insemination (TDI) protocol in lieu of unprotected intercourse — the specific number of TDI cycles required before IVF is authorized is determined by the treating physician, not a fixed insurer-imposed cycle count. Claims for same-sex or single patients must be supported by documentation of the TDI protocol used.

Covered Fertility Services Under the Illinois Mandate

The Illinois mandate requires coverage across the full spectrum of infertility diagnosis and treatment. Services that must be covered under compliant Illinois group plans include:

• Diagnostic infertility workup — labs (FSH, LH, estradiol, AMH, prolactin, thyroid panel), semen analysis (89300, 89310, 89320, 89322), hysterosalpingography (HSG; CPT 74740), ovarian reserve testing including antral follicle count (76830), diagnostic hysteroscopy (58555), diagnostic laparoscopy (49320, 58660), and endometrial biopsy (58100)
• IUI (intrauterine insemination) — sperm preparation/wash (89260) and the insemination procedure (58322); most Illinois plans do not impose a hard IUI cycle cap under the mandate, though plan documents may specify limits
• IVF (in vitro fertilization) — complete fresh cycle including ovarian stimulation, ultrasound and hormonal monitoring, oocyte retrieval (58970 with 76948 for ultrasound guidance), embryo culture (89250), conventional insemination (89268), ICSI (89280 for ≤10 oocytes; 89281 for >10 oocytes), extended embryo culture (89272), and embryo transfer (58974)
• Embryo cryopreservation and frozen embryo transfer (FET) — embryo freezing (89258), embryo thaw (89352), and FET procedure (58974 or 58976); most Illinois fully insured plans cover FET cycles, though plan language on whether FETs count against the retrieval lifetime cap varies by carrier
• Embryo biopsy for PGT (preimplantation genetic testing) — 89290 (biopsy, ≤5 specimens) and 89291 (biopsy, >5 specimens); PGT coverage is carrier-specific; many Illinois plans cover PGT-A when medically indicated (advanced maternal age, recurrent pregnancy loss, prior aneuploid pregnancy) with a separate PA; PGT-M and PGT-SR require additional medical necessity documentation
• GIFT (gamete intrafallopian transfer) and ZIFT (zygote intrafallopian transfer) — covered under the mandate; rarely performed clinically today but included in the statutory coverage list
• Iatrogenic fertility preservation — egg cryopreservation (89337) prior to gonadotoxic treatment (chemotherapy, pelvic radiation) is covered under most Illinois plans regardless of the fertility mandate, using oncology primary diagnoses rather than infertility codes; do not bill iatrogenic preservation with N97.x codes

The mandate does not require coverage for: elective (social) egg freezing in patients without a fertility-threatening medical diagnosis; gestational carrier fees paid to a third-party surrogate; sperm or egg donor acquisition or compensation fees (though monitoring and procedure costs for a donor recipient cycle are typically covered for the recipient patient); and procedures classified as experimental under the applicable carrier's fertility medical policy.

Benefit Limits and Lifetime Cycle Tracking

Unlike New York's unlimited IVF mandate, the Illinois statute permits carriers to impose a lifetime benefit cap on covered retrieval cycles. Most Illinois-regulated fully insured plans limit coverage to 4 oocyte retrieval cycles per covered lifetime. Some plans apply a shared dollar-based lifetime maximum across all fertility services rather than a per-cycle cap. At initial patient eligibility verification, collect the following from the insurer in writing:

• The total number of covered IVF retrieval cycles remaining in the patient's lifetime benefit and, if applicable, how many have already been used across all facilities
• Whether FET cycles count against the 4-retrieval lifetime cap or are separately categorized as a distinct benefit
• Whether IUI cycles are capped and, if so, the number of covered cycles remaining
• Whether a lifetime dollar maximum applies across all infertility services in lieu of or in addition to a cycle count
• The plan's definition of a "completed" IVF cycle — specifically whether a cancelled stimulation cycle in which no egg retrieval was performed counts against the lifetime cap
• Whether PGT-A, PGT-M, or PGT-SR cycles require separate prior authorization distinct from the IVF retrieval authorization
• The specific prior authorization vendor and submission portal for fertility services (many BCBS IL plans delegate to AIM Specialty Health, not BCBS directly)

CPT Code Reference for Illinois Mandate Fertility Services

ICD-10 Diagnosis Coding for Illinois Mandate Claims

Accurate ICD-10 coding determines whether a fertility claim routes to the mandate benefit or triggers medical necessity review. Carriers use the primary diagnosis code to validate mandate applicability. Non-specific or mismatched codes generate additional documentation requests that delay payment or result in denial.

Primary infertility diagnosis codes for Illinois mandate claims: N97.0 (female infertility associated with anovulation — use for PCOS, anovulatory cycles); N97.1 (female infertility of tubal origin — use for documented tubal factor, prior ectopic, tubal ligation reversal); N97.2 (female infertility of uterine origin — use for uterine anomaly, Asherman's syndrome, submucosal fibroid); N97.8 (female infertility of other or combined origin — appropriate for combined factor or when two distinct etiologies are present); N97.9 (female infertility, unspecified — use only when no etiology can be documented; avoid as primary code when any etiology is available, as it is the weakest code for medical necessity defense). Male factor codes: N46.01 (organic azoospermia), N46.11 (organic oligospermia), N46.021–N46.029 (azoospermia by specific etiology — e.g., N46.022 for azoospermia due to infection), N46.121–N46.129 (oligospermia by specific etiology). Supporting secondary codes: E28.2 (polycystic ovarian syndrome), N80.101–N80.9 (endometriosis by anatomical site), Z31.41 (encounter for fertility testing), Z31.62 (encounter for fertility preservation procedure — use only for iatrogenic cases). For iatrogenic fertility preservation, lead with the oncology primary diagnosis (e.g., C50.x for breast cancer) and add Z31.62 as a secondary code — never use N97.x for these patients.

Prior Authorization Requirements by Major Illinois Carrier

Every major Illinois carrier requires prior authorization for IVF and most monitored IUI cycles under their mandate-compliant fully insured plans. Authorization submission pathways differ by carrier, and routing a PA to the wrong entity results in no authorization being issued, which produces a denial at adjudication even when the service is clinically appropriate and mandate-compliant.

• BlueCross BlueShield of Illinois (BCBS IL) — The dominant fully insured carrier in Illinois by enrollment. BCBS IL delegates fertility prior authorization for the majority of its fully insured group products to AIM Specialty Health. IVF and IUI PA requests must be submitted through the AIM Specialty Health portal (aimspecialtyhealth.com), not directly to BCBS IL. Submitting to BCBS directly results in no authorization being issued in AIM's system — when the claim adjudicates, AIM has no record of approval and the claim denies for lack of PA. Confirm the authorization vendor at every initial eligibility call. Some BCBS IL products (state employee plans, smaller local plans) retain PA in-house — verify annually, as carrier-vendor relationships change. Standard AIM turnaround is 3-5 business days; request expedited review (24-48 hours) when a cycle is medically time-sensitive. PA is typically issued for 90 days; FET cycles require standalone PA separate from the IVF retrieval authorization.
• Aetna Illinois — Aetna handles fertility PA in-house for Illinois fully insured group plans through its national fertility PA process. Submit via the Aetna provider portal or by phone to the Aetna fertility PA team. Aetna requires documentation of the infertility diagnosis and etiology, duration of infertility, prior treatment history, and the physician's treatment plan. For IVF, Aetna's clinical criteria generally require either failed prior IUI cycles (typically 3, unless IUI is contraindicated) or a documented clinical indication for proceeding directly to IVF. Authorization is typically valid for 90 days. FET and PGT each require separate authorization from the IVF retrieval PA.
• UnitedHealthcare Illinois — UHC has expanded delegation of fertility PA to Optum for some Illinois products. Confirm the correct PA submission pathway at eligibility verification — submitting fertility PA through UHC's standard PA portal when the plan routes fertility through Optum creates a parallel authorization problem. UHC's fertility clinical criteria under Illinois mandate plans include documented infertility meeting the statutory definition, clinical indication for the proposed service, and physician treatment plan. UHC may apply its national fertility medical policy or a modified policy specific to the Illinois mandate product — obtain the applicable clinical criteria document from your provider relations contact.
• Cigna Illinois — Cigna's national fertility PA process applies to Illinois fully insured plans. Submit through the Cigna provider portal or via phone to the specialty PA team. Cigna's IVF criteria may include a 3-cycle IUI requirement prior to IVF, even for Illinois mandate patients — review the specific plan document, because applying this requirement to a patient with a contraindication to IUI (severe male factor, bilateral tubal occlusion, prior IUI failures) is an appealable restriction under the Illinois mandate. Document the clinical contraindication explicitly in the PA package and cite the mandate when Cigna's criteria conflict with medically necessary IVF coverage. Auth is typically valid for 90 days.
• Humana Illinois — Humana has a limited fully insured plan presence in Illinois; many Humana-administered Illinois employer plans are self-funded and not subject to the mandate. Verify plan funding type before assuming mandate coverage applies. For fully insured Humana Illinois plans, fertility PA is submitted through the Humana provider portal. Coverage and clinical criteria mirror Humana's national fertility policy subject to Illinois mandate minimums.

FET Billing Under Illinois Mandate Plans

FET billing is a frequent source of claim denials under Illinois mandate plans because many billing teams apply the IVF retrieval authorization number to FET claims — this generates a clinical inconsistency denial at adjudication. The FET CPT codes (89352 for embryo thaw; 58974 for embryo transfer) fall outside the scope of a retrieval authorization. Every FET cycle requires its own standalone prior authorization, submitted and approved before the FET monitoring begins.

Whether FET cycles count against the Illinois plan's lifetime retrieval cap is carrier-specific and must be confirmed in writing. BCBS IL plans administered through AIM generally do not count FETs against the 4-retrieval lifetime limit — FETs are authorized as a separate service category. Aetna Illinois plans may apply a combined cycle limit that includes both retrievals and FETs. UHC and Cigna plans vary by specific plan document. When a patient transfers from another clinic with frozen embryos, obtain the prior clinic's cycle history documentation and confirm with the current insurer whether those FETs have been reported against the patient's lifetime benefit.

For practices billing embryo storage fees, most Illinois carriers do not cover annual embryo storage charges under the mandate — storage fees are typically a patient responsibility or covered under a separate benefit rider. Confirm storage coverage at initial eligibility verification and communicate the patient's financial responsibility in writing before the embryos are frozen.

Common Illinois Mandate Billing Errors and Prevention

• Treating self-funded plans as mandate-compliant: The Illinois mandate does not apply to ERISA self-funded plans. Claims submitted as mandate-required to a self-funded plan that has not elected fertility coverage produce uncollectible write-offs. Prevention: confirm plan funding type in writing at every initial eligibility call and document it in the patient's billing record before treatment begins.
• Routing BCBS IL fertility PA directly to BCBS instead of through AIM Specialty Health: For most BCBS IL fully insured group products, fertility PA must be submitted through AIM — not BCBS directly. Submitting to BCBS produces no authorization in AIM's system and results in a no-PA denial at adjudication. Prevention: build an AIM portal submission step into your BCBS IL PA workflow and audit carrier-to-vendor routing at least annually.
• Applying the IVF retrieval authorization to FET claims: FET claims billed under the retrieval auth number are denied for clinical inconsistency. The FET CPT codes are not within scope of a retrieval authorization. Prevention: create a mandatory FET authorization trigger in your cycle management workflow that activates when a freeze-all cycle completes, when PGT results return, or when a fresh transfer is cancelled.
• Submitting PGT biopsy codes without PGT-specific prior authorization: Most Illinois carriers require separate PA for PGT (89290, 89291) distinct from the IVF retrieval authorization. Billing these codes under the IVF retrieval auth generates a denial. Prevention: build PGT PA as a discrete workflow step whenever PGT is planned, and confirm the PGT auth number is separate from the retrieval auth before submitting biopsy claims.
• Using infertility diagnosis codes for iatrogenic fertility preservation: Applying N97.x to an oncology patient's pre-chemotherapy egg freeze triggers medical necessity review under infertility criteria, which the patient does not meet. The claim denies. Prevention: use the oncology primary diagnosis plus Z31.62 for all iatrogenic preservation claims and never apply infertility codes to this patient population.
• Logging cancelled stimulation cycles as consumed retrievals: Incorrectly recording a stimulation-only cycle with no egg retrieval as a lifetime cap cycle tells the patient they have fewer remaining benefits than they actually do and may result in collecting an out-of-pocket payment that should be billed to insurance. Prevention: define "completed retrieval" in your cycle tracking system to require an egg retrieval procedure date and confirm each carrier's counting definition in writing.
• Missing TDI documentation for same-sex or single patient PA submissions: Illinois mandate claims for same-sex couples and single individuals must be supported by documentation of a physician-supervised TDI protocol. PA packages submitted without TDI cycle records are returned for supplemental documentation, delaying the authorization and potentially pushing the cycle start date. Prevention: create a same-sex/single patient intake checklist with TDI documentation collection as a required step before the PA submission date.

Appealing Illinois Mandate Denials

Fully insured Illinois health plans are subject to robust appeal rights under the Illinois Insurance Code and the ACA. After exhausting the plan's internal appeal process, patients and providers may request external independent review through the Illinois Department of Insurance. External review decisions are binding on fully insured Illinois insurers. Self-funded plans are not subject to Illinois external review — ERISA plans have their own limited internal appeal and federal external review rights.

For Illinois mandate medical necessity denials, the appeal package should include: the complete infertility workup documentation establishing the diagnosis and etiology; confirmation that the patient meets the Illinois statutory infertility definition (including TDI protocol records for same-sex or single patients); prior treatment history relevant to the proposed service; the treating REI physician's signed letter of medical necessity; applicable ASRM Practice Committee Opinion guidelines; peer-reviewed literature supporting the proposed treatment for the patient's specific clinical presentation; and the plan's own fertility clinical criteria with a written argument identifying where those criteria conflict with 215 ILCS 5/356m. When a carrier (most commonly Cigna) applies a mandatory IUI cycle requirement prior to IVF for a patient with a documented contraindication to IUI, the appeal should explicitly cite the mandate's requirement to cover medically necessary IVF and the clinical basis for bypassing IUI cycles.

Request a peer-to-peer review with the plan's medical director for time-sensitive denials. Submit the P2P request within 48 hours of the denial notice when a cycle cannot be delayed. For BCBS IL plans with PA delegated to AIM Specialty Health, the P2P call is with an AIM physician reviewer — not a BCBS medical director. AIM P2P calls are typically scheduled within 2 business days. Document the outcome of the verbal P2P in writing immediately after the call and follow up if written authorization is not issued within 24 hours.

Quarterly Billing Audit Checklist for Illinois Practices

A structured quarterly audit of Illinois mandate billing should verify: every IVF, FET, and PGT claim has a matching authorization number in the billing system before submission; BCBS IL fertility PA is routed through AIM Specialty Health and not submitted directly to BCBS; plan funding type (fully insured vs. self-funded) is documented at the patient level and visible in the billing workflow before any cycle services are rendered; lifetime retrieval cycle counts are accurate, updated after each retrieval procedure, and confirmed against carrier-held records at the start of each new patient relationship; same-sex and single patient files contain TDI protocol documentation collected before the first PA submission; FET authorizations are standalone and not linked to the associated IVF retrieval authorization number; and all denial-to-appeal turnaround times are within the plan-specific internal appeal deadline (typically 180 days from denial) and ACA external review eligibility windows.